J. B. Chemicals & Pharmaceuticals Limited

Simbol: JBCHEPHARM.NS

NSE

1743.85

INR

Tržna cena danes

  • 53.2431

    Razmerje P/E

  • 8.4545

    Razmerje PEG

  • 270.64B

    Kapaciteta MRK

  • 0.01%

    Donos DIV

J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja J. B. Chemicals & Pharmaceuticals Limited, opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

02928.6566.56936.6
3628.2
3960.5
4117.1
2337.1
2072.5
5723.6
5058.1
4117
5184.5
1950
1375.4
1018.4
750.9
577
381

balance-sheet.row.short-term-investments

02159.31.16649.7
3338.1
3606.5
3837.7
2249.6
1952.5
5559.5
4972.6
3979.8
2989.2
681.1
596.8
580
601.3
373.1
265

balance-sheet.row.net-receivables

05771.76238.84186.7
3613.5
4068.4
4215.6
2726.7
29.6
16.9
32.5
4274.7
1360.5
0
0
3028
3224.2
0
0

balance-sheet.row.inventory

04304.94099.63474.5
2746.7
2437.6
2137.3
2001.7
1879.8
1502.7
1344
1045.3
1010.3
1116.7
834.7
807.7
746.9
835.7
643.1

balance-sheet.row.other-current-assets

02275.11843.6928.2
4352.4
29.3
0
883.4
3795.7
3586.9
3371.8
0
1106.8
3455.8
3448.2
0
0
3133.1
2526.5

balance-sheet.row.total-current-assets

015280.312748.515526
10727.3
10495.8
10470
7948.9
7777.6
10830.2
9806.5
9437.1
8662.2
6522.5
5658.4
4854.2
4722.1
4545.8
3550.6

balance-sheet.row.property-plant-equipment-net

05764.25668.25696.6
5842
5595.1
5811.1
6010.3
5019
3590.6
3316.2
3001.1
2791.9
2446.6
2263.8
2327.1
2443
2333.1
1473

balance-sheet.row.goodwill

0574.6574.6574.6
531.4
531.4
531.4
531.4
531.4
169
169
169
0
169
169
169
169
169
0

balance-sheet.row.intangible-assets

013222.86713.9321.1
300.9
233.8
226.5
290.3
162.3
77.8
83.8
221.1
360.4
4.7
34.9
37.1
3.7
0.1
0

balance-sheet.row.goodwill-and-intangible-assets

013797.47288.5895.6
832.3
765.2
757.9
821.7
693.7
246.8
252.8
390.1
360.4
173.7
204
206.1
172.7
169.1
0

balance-sheet.row.long-term-investments

0137.8127.2129.1
694.5
958.8
-3336.6
-337.7
-104.2
-5461.1
-4945
-3916.8
-2959.3
168.7
-354.1
-505.1
-526.1
-298.3
-236

balance-sheet.row.tax-assets

065.164.369.4
39.5
203.1
368.9
2264.1
2187.8
-246.8
-252.8
4090.4
2989.2
681.1
596.8
580
601.3
373.1
0

balance-sheet.row.other-non-current-assets

0493.9177.264.4
0
-107.9
3577.5
33.1
0
5912.8
5332.5
0.2
133.5
1.2
0.8
0.8
0
0.1
265.1

balance-sheet.row.total-non-current-assets

020258.413325.56855.1
7408.3
7414.3
7178.9
8791.5
7796.3
4042.3
3703.7
3564.9
3315.8
3471.3
2711.3
2608.9
2691
2577.1
1502.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

035538.72607422381.2
18135.6
17910
17648.9
16740.4
15573.8
14872.5
13510.1
13002
11978
9993.8
8369.7
7463.1
7413.1
7122.9
5052.8

balance-sheet.row.account-payables

02386.42244.81869.2
1237.9
827.6
1104
989.8
908.5
775.1
607.5
605.1
370.9
504.5
455
386.6
441.5
634.8
258.7

balance-sheet.row.short-term-debt

01739.1339.4398.5
369.9
258
292.9
488.6
1930.2
1266.2
813.9
368.8
552.3
0
0
0
0
0
0

balance-sheet.row.tax-payables

049.560.979
60.2
39.4
1.5
8.7
3665
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

03985.4206.251.4
12.3
35.3
60.7
86.1
0
4
0.9
2.2
125.5
1690.6
1367.6
1787.7
1963.5
1743.7
956.3

Deferred Revenue Non Current

0152.131.749.3
59.7
22
36
39.5
0
116.3
121.9
152.5
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0236.588.299.4
16.5
7.1
0
0
220
2.4
91.6
70.7
787.5
720.6
707.4
471.5
323
374.9
379.9

balance-sheet.row.total-non-current-liabilities

05190.7850.7794.1
627.2
648.4
456.6
269.8
262.6
326.2
319.3
409.6
395.2
1853.3
1526.1
1916.1
2118.3
1928.6
1110.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0242.1282.4123.4
61.8
12.3
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

010735.24687.94246.9
3755.7
3080.7
3205.6
3081.9
4620.6
4923.7
3082
2799.3
2278.5
3078.4
2688.5
2774.2
2882.8
2938.3
1749

balance-sheet.row.preferred-stock

0000
20913.2
22450.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0154.8154.6154.6
154.6
160.5
167.1
169.6
169.6
169.6
169.5
169.4
169.4
169
168.7
168.7
168.7
168.7
160.7

balance-sheet.row.retained-earnings

022757.118427.115847.9
12329.5
11024.3
9291.2
8066.1
5405.7
4312.3
4792.5
4543.5
4134.1
6746.4
5512.5
4520.3
4361.6
4015.9
3143

balance-sheet.row.accumulated-other-comprehensive-income-loss

02698.82248.41583.6
-5154.1
-4534.5
-4045.8
-3503.1
-3058.1
-2664.6
-2244.6
-1984.9
-1761.5
-1581.3
-1398.9
-1198.6
-1006.3
-839.4
-722.9

balance-sheet.row.other-total-stockholders-equity

0-807.1511.2511.2
-13888.3
-14299.2
9003.1
8904
8420.1
8131.5
7710.7
7474.7
7157.5
1581.3
1398.9
1198.6
1006.3
839.5
722.9

balance-sheet.row.total-stockholders-equity

024803.521341.218097.2
14354.9
14801.2
14415.6
13636.7
10937.3
9948.7
10428.1
10202.7
9699.5
6915.4
5681.2
4688.9
4530.2
4184.6
3303.8

balance-sheet.row.total-liabilities-and-stockholders-equity

035538.72607422381.2
18135.6
17910
17648.9
16740.4
15573.8
14872.5
13510.1
13002
11978
9993.8
8369.7
7463.1
7413.1
7122.9
5052.8

balance-sheet.row.minority-interest

0044.937.1
25
28
27.7
21.8
16
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

024803.521386.118134.3
14379.9
14829.3
14443.3
13658.5
10953.3
9948.7
10428.1
10202.7
9699.5
6915.4
5681.2
4688.9
4530.2
4184.6
3303.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0323.9128.1130.9
695.9
960.3
501.1
1923.3
1848.3
28.3
28.4
29.9
30
849.8
242.7
74.9
75.2
74.9
29

balance-sheet.row.total-debt

05724.5545.6449.9
382.2
258
292.9
488.6
1930.2
1266.2
814.8
370.9
677.7
1690.6
1367.6
1787.7
1963.5
1743.7
956.3

balance-sheet.row.net-debt

04955.2-19.9163
92.1
-96
13.5
401.2
1810.2
1102.1
729.3
233.7
-1517.6
421.7
588.9
1349.2
1813.9
1539.8
840.3

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju J. B. Chemicals & Pharmaceuticals Limited opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

cash-flows.row.net-income

05552.350495968.9
3488.9
2869.9
1939.5
2299.4
2088.2
1455.5
874.5
1035.7
8434.4
1653.4
1480.7
370.6
436.9
827
662.1

cash-flows.row.depreciation-and-amortization

01144.1726.6686.7
663.2
556.4
569.7
472.2
412.4
386.4
280.2
246.6
224.2
227.9
215.7
204.3
169
107.3
104.9

cash-flows.row.deferred-income-tax

0-1146.7-1685.90
0
0
0
0
0
0
0
0
0
0
-293.2
-113.5
111.7
0
0

cash-flows.row.stock-based-compensation

0693.7626.50
0
0
0
0
0
0
0
0
0
0
0
0
0.6
0
0

cash-flows.row.change-in-working-capital

0-299.2-3025.2-942.1
93.2
-519.5
-478.3
27.7
-173.3
-195.2
-937.1
94.7
1673.5
-158.7
-227.7
17.5
-427.3
-623.6
-433.2

cash-flows.row.account-receivables

0-417.5-2928.4-706
-115
-138.8
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-205.2-625.1-700.9
-309.1
-300.3
-135.6
-121.9
-179.5
-158.7
-298.7
-35
106.4
-282
-27
-60.8
88.8
-115.2
-97.7

cash-flows.row.account-payables

0323.5528.3464.8
521.1
-285.7
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
-3.8
205.2
-342.6
149.6
6.2
-36.5
-638.4
129.7
1567.1
123.3
-200.8
78.3
-516.1
-508.4
-335.5

cash-flows.row.other-non-cash-items

0311.910.3-2565.6
-1491.7
-976
-800.5
-797.4
-930.6
-380
-357.4
-527.7
-1535.2
-384.4
44.3
432.2
-7.8
-87.8
-108.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-7649.5-7067.9-477.7
-729.7
-483.4
-365.6
-1561.7
-1994.6
-711.9
-603.9
-492.1
-801
-343.6
-126.3
-157
-284.6
-235.5
-178.9

cash-flows.row.acquisitions-net

01998.6-7003.9-85
65.5
105
97.4
12.9
-523
16.8
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-7568.7-5084.7-5412.1
-3826.8
-4252.3
-4200.6
-1834.5
-1993
-2460.8
-3913
-6018.1
-17174.2
-4578.7
-207.6
-0.6
-0.3
-1.8
-2.1

cash-flows.row.sales-maturities-of-investments

05570.112088.63169.1
4739.3
4356
4234
2920.9
4045.5
2036.9
3070.5
5290
15022.9
3976.9
26.4
0
0
2.5
0.6

cash-flows.row.other-investing-activites

0-1968.47091.1498.9
-5.4
5.8
26.6
26.9
144.8
0
21.5
59.7
343.1
50.8
12.9
14.5
4.3
9.3
7.1

cash-flows.row.net-cash-used-for-investing-activites

0-9617.923.2-2306.8
243
-268.9
-208.1
-435.5
-320.3
-1118.9
-1425
-1160.5
-2609.2
-894.6
-294.6
-143.1
-280.6
-225.6
-173.3

cash-flows.row.debt-repayment

0-872.5-3.3-3.2
-63.1
-0.5
0
0
-0.9
-1.3
-1.2
-177.2
-1019.5
-248.6
-486.6
-429.4
-313.6
-49.1
-35.5

cash-flows.row.common-stock-issued

084.800
-63.1
0.5
0
0
1.1
7.1
2.1
0
15.8
14.9
0
0
0
4.6
0

cash-flows.row.common-stock-repurchased

05684.800
-1608.2
-1310.3
-500
0
665.7
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-1275.9-1275.6-732.4
-1410
-207.9
-103.4
-57.4
-1875.4
-297.2
-298.3
-99.9
-4121.8
-196.5
-98.4
-49.6
-148
-228.4
-208.3

cash-flows.row.other-financing-activites

0-55.8-105-138.6
84
-34.7
8.1
-1771.7
13.7
277.5
417.9
-44.8
-135.7
476.9
0
0
404.9
296.8
228.3

cash-flows.row.net-cash-used-provided-by-financing-activities

03565.4-1383.9-874.2
-3060.5
-1552.9
-595.2
-1829
-1195.8
-13.9
120.4
-321.8
-5261.2
46.6
-584.9
-479.1
-56.7
23.9
-15.4

cash-flows.row.effect-of-forex-changes-on-cash

00.300.4
-0.1
-0.2
0
0
17.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0203.9340.7-32.8
-63.9
109
427.2
-262.6
-102.3
133.8
-1444.3
-633
926.5
490.2
340.2
288.8
-54.2
21.1
36.8

cash-flows.row.cash-at-end-of-period

0769.3565.4224.7
257.5
321.4
212.4
-168.3
149.6
251.9
118.1
1562.3
2195.3
1268.9
778.6
438.5
149.6
116
94.9

cash-flows.row.cash-at-beginning-of-period

0565.4224.7257.5
321.4
212.4
-214.7
94.2
251.9
118.1
1562.3
2195.3
1268.9
778.6
438.5
149.6
203.9
94.9
58.1

cash-flows.row.operating-cash-flow

06256.11701.33147.8
2753.7
1930.8
1230.5
2002
1396.7
1266.6
-139.8
849.3
8796.9
1338.2
1219.7
911.1
283.1
222.8
225.5

cash-flows.row.capital-expenditure

0-7649.5-7067.9-477.7
-729.7
-483.4
-365.6
-1561.7
-1994.6
-711.9
-603.9
-492.1
-801
-343.6
-126.3
-157
-284.6
-235.5
-178.9

cash-flows.row.free-cash-flow

0-1393.4-5366.52670.1
2024
1447.3
864.9
440.3
-598
554.8
-743.7
357.2
7995.9
994.6
1093.4
754
-1.5
-12.7
46.6

Vrstica izkaza poslovnega izida

Prihodki J. B. Chemicals & Pharmaceuticals Limited so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja JBCHEPHARM.NS znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005

income-statement-row.row.total-revenue

031492.824242.420058.5
17427
16102.3
13851.2
13103.9
11681.9
10487.6
9386.2
7858.4
8018.7
8416.3
7409.7
7170.9
5624
5255.7
4657

income-statement-row.row.cost-of-revenue

03842.28633.77174.4
6542.7
6213.2
5617
5523.8
5198.5
4751.2
4349.2
3829.6
3598.9
2739.7
-32.2
58.5
83.9
-7.3
-57

income-statement-row.row.gross-profit

027650.615608.712884.1
10884.4
9889.1
8234.2
7580.1
6483.4
5736.3
5037
4028.8
4419.8
5676.6
7441.9
7112.4
5540.1
5263.1
4714

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

099.48.476.2
67.8
24.5
58.3
62.8
7
5532.4
177.5
11.9
-84.5
4218.7
5961.2
6741.8
5103.2
4551.5
3887

income-statement-row.row.operating-expenses

013997.410862.78009.7
7704.8
7305.7
6615.8
5739
5008
4571.4
4148.3
3526.1
3263.9
4218.7
5961.2
6741.8
5103.2
4551.5
3887

income-statement-row.row.cost-and-expenses

03842.219496.515184.1
14247.4
13518.9
12232.8
11262.8
10206.5
9322.6
8497.5
7355.7
6862.8
6958.5
5929
6800.3
5187.2
4544.2
3830

income-statement-row.row.interest-income

025.49.317.7
28.5
23
16.8
11.8
11
13.3
13.2
12.6
85.6
0
0
0
0
0
0

income-statement-row.row.interest-expense

0360.547.969.4
29.2
38.7
31.4
49.1
22.1
33.5
27.1
38.6
240.3
104.9
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-365.6310.11073.4
306.8
287.4
263.2
345.8
123.3
40.7
-333.5
-19.6
7278.6
195.5
0
0
0
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

099.48.476.2
67.8
24.5
58.3
62.8
7
5532.4
177.5
11.9
-84.5
4218.7
5961.2
6741.8
5103.2
4551.5
3887

income-statement-row.row.total-operating-expenses

0-365.6310.11073.4
306.8
287.4
263.2
345.8
123.3
40.7
-333.5
-19.6
7278.6
195.5
0
0
0
0
0

income-statement-row.row.interest-expense

0360.547.969.4
29.2
38.7
31.4
49.1
22.1
33.5
27.1
38.6
240.3
104.9
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

01144.1726.6686.7
663.2
556.4
569.7
472.2
412.4
386.4
280.2
246.6
224.2
227.9
215.7
204.3
169
107.3
104.9

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

05917.947394895.4
3182.2
2582.6
1676.3
2299.4
2088.2
1455.5
874.5
1035.7
1330.5
1457.9
1480.7
370.6
436.9
711.5
827

income-statement-row.row.income-before-tax

027650.650495968.9
3488.9
2869.9
1939.5
2299.4
2088.2
1455.5
874.5
1035.7
8434.4
1653.4
1480.7
370.6
436.9
711.5
827

income-statement-row.row.income-tax-expense

0893.11188.61483.6
765
930.2
552.3
455.5
469.1
451.4
259.5
241.3
1655.3
260.2
293.2
113.5
16.3
89.8
124.6

income-statement-row.row.net-income

04098.33853.64479.6
2720.5
1934.7
1383.4
1840.6
1618.8
1004.1
615
794.4
6779.1
1393.2
1187.5
257.1
453.2
621.8
702.4

Pogosto zastavljeno vprašanje

Kaj je J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) skupna sredstva?

J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) skupna sredstva so 35538700000.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.890.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 14.157.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.152.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.855.

Kaj je J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 4098300000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 5724500000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 13997400000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.